ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.

Holsten, Till; Bronsema, Annika; Sturm, Dominik; Sahm, Felix; Rutkowski, Stefan; Schüller, Ulrich; Wößmann, Wilhelm; Kordes, Uwe R

Holsten, Till; Bronsema, Annika; Sturm, Dominik; Sahm, Felix; Rutkowski, Stefan; Schüller, Ulrich; Wößmann, Wilhelm; Kordes, Uwe R.

Afiliação

Holsten T; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bronsema A; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sturm D; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Pediatric Glioma Research, Germany.
Sahm F; Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Rutkowski S; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Schüller U; Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Wößmann W; Department of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany.
Kordes UR; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Pediatr Blood Cancer ; 69(8): e29594, 2022 08.

Article em En | MEDLINE | ID: mdl-35195346

Assuntos

Neoplasias Pulmonares; Terapia de Salvação; Fusão Gênica; Humanos; Neoplasias Pulmonares/patologia; Proteínas de Fusão Oncogênica/genética; Receptores Proteína Tirosina Quinases/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Salvação / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google